These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Intravenous use of enoximone. Crawford MH Am J Cardiol; 1987 Aug; 60(5):42C-45C. PubMed ID: 2956867 [TBL] [Abstract][Full Text] [Related]
15. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure. Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735 [TBL] [Abstract][Full Text] [Related]
16. [Enoximone: hemodynamic effect in patients with cardiac insufficiency]. de Langenhagen B; Bouchoucha H; Scholl JM; Hennetier G; Benacerraf A; Achard F; Bock F Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830 [TBL] [Abstract][Full Text] [Related]
17. Short-term effects of oral enoximone on hemodynamics, exercise capacity, anaerobic threshold, and arrhythmias in congestive heart failure. Klauss V; Zwehl W; Mudra H; Huber R; Schmidt R; Scheininger M; Vogler A; Tschaidse O; Dieterich HA; Theisen K Klin Wochenschr; 1991 Jul; 69(10):430-5. PubMed ID: 1719270 [TBL] [Abstract][Full Text] [Related]
18. Addition of enoximone to adrenergic agents in the management of severe heart failure. Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ Crit Care Med; 1992 Aug; 20(8):1102-6. PubMed ID: 1386567 [TBL] [Abstract][Full Text] [Related]
19. MDL 17,043 therapy in severe congestive heart failure: characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response. Uretsky BF; Generalovich T; Verbalis JG; Valdes AM; Reddy PS J Am Coll Cardiol; 1985 Jun; 5(6):1414-21. PubMed ID: 3158689 [TBL] [Abstract][Full Text] [Related]